Silencing WDFY3-AS2 notably hinders the proliferation, migration and invasion of oral squamous cells but accelerates cell apoptosis and can be applied to be a new therapeutic target and prognostic factor for oral squamous cell carcinoma [26]. Here, WDFY3 is linked to oral cavity squamous cell carcinoma.